DrugPatentWatch Database Preview
Details for Patent: 7,622,130
Which drugs does patent 7,622,130 protect, and when does it expire?
Patent 7,622,130 protects KYBELLA and is included in one NDA.
This patent has fifty-five patent family members in twenty-two countries.
Summary for Patent: 7,622,130
| Title: | Methods and compositions for the non-surgical removal of fat |
| Abstract: | Compositions and methods useful in the non-surgical removal of localized fat deposits in patients in need thereof using pharmacologically active detergents are disclosed. The pharmacologically active detergent compositions can additionally include anti-inflammatory agents, analgesics, dispersion agents and pharmaceutically acceptable excipients but do not contain phosphotidylcholine. The pharmacologically active detergent compositions are useful for treating localized accumulations of fat including lower eyelid fat herniation, lipodystrophy and fat deposits associated with cellulite and do not require surgical procedures such as liposuction. |
| Inventor(s): | Kolodney; Michael S. (Santa Monica, CA), Rotunda; Adam M. (Los Angeles, CA) |
| Assignee: | Los Angeles Biomedical Research Institute at Harbor UCLA-Medical Center (Torrance, CA) The Regents of the University of California (Oakland, CA) |
| Application Number: | 11/054,171 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,622,130 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 7,622,130
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kythera Biopharms | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | RX | Yes | Yes | Start Trial | Start Trial | METHOD FOR REDUCTION OF SUBMENTAL FAT | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,622,130
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 518565 | Start Trial | |||
| Austria | 521355 | Start Trial | |||
| Australia | 2005245002 | Start Trial | |||
| Canada | 2567298 | Start Trial | |||
| China | 101018553 | Start Trial | |||
| China | 105233287 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
